STOCK TITAN

Csx Corp Financials

CSX
FY2025 annual
Revenue $14.1B -3.1% YoY
Net Income $2.9B -16.7% YoY
EPS (Diluted) $1.54 -14.0% YoY
Free Cash Flow $1.7B -37.0% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Csx Corp (CSX) reported $14.1B in revenue for fiscal year 2025, down 3.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CSX FY2025

Rising reinvestment needs are absorbing a larger share of cash as profitability softens and the balance sheet stays levered.

Between FY2023 and FY2025, free cash flow fell from $3.26B to $1.71B even though revenue changed far less over the same span. With operating margin sliding to 32.1% while capital spending climbed to $2.90B, the squeeze is coming from both weaker profit per revenue dollar and more cash required to maintain the asset base than the income statement alone implies.

The company still shows solid cash conversion before reinvestment: FY2025 operating cash flow was $4.61B against net income of $2.89B. That means reported profit is still turning into cash, and the bigger constraint is capital intensity rather than a disconnect between earnings and cash generation.

The liquidity cushion has tightened as cash fell to $670M and the current ratio slipped to 0.8x. Long-term debt stayed near $18.2B, so buybacks dropping to $1.40B suggests cash is being conserved rather than balance-sheet leverage being materially reduced.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 53 / 100
Financial Health Score 53/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Csx Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
95

Csx Corp has an operating margin of 32.1%, meaning the company retains $32 of operating profit per $100 of revenue. This strong profitability earns a score of 95/100, reflecting efficient cost management and pricing power. This is down from 36.1% the prior year.

Growth
25

Csx Corp's revenue declined 3.1% year-over-year, from $14.5B to $14.1B. This contraction results in a growth score of 25/100.

Leverage
22

Csx Corp has elevated debt relative to equity (D/E of 1.38), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 22/100, reflecting increased financial risk.

Liquidity
12

Csx Corp's current ratio of 0.81 is below the typical benchmark, resulting in a score of 12/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
81

Csx Corp converts 12.1% of revenue into free cash flow ($1.7B). This strong cash generation earns a score of 81/100.

Returns
80

Csx Corp earns a strong 21.9% return on equity (ROE), meaning it generates $22 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 80/100. This is down from 27.7% the prior year.

Altman Z-Score Grey Zone
2.83

Csx Corp scores 2.83, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($93.7B) relative to total liabilities ($30.5B). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

Csx Corp passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.60x

For every $1 of reported earnings, Csx Corp generates $1.60 in operating cash flow ($4.6B OCF vs $2.9B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
5.36x

Csx Corp earns $5.36 in operating income for every $1 of interest expense ($4.5B vs $844.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$14.1B
YoY-3.1%
5Y CAGR+5.9%
10Y CAGR+1.8%

Csx Corp generated $14.1B in revenue in fiscal year 2025. This represents a decrease of 3.1% from the prior year.

EBITDA
$6.2B
YoY-10.2%
5Y CAGR+1.5%
10Y CAGR+2.6%

Csx Corp's EBITDA was $6.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 10.2% from the prior year.

Net Income
$2.9B
YoY-16.7%
5Y CAGR+0.9%
10Y CAGR+3.9%

Csx Corp reported $2.9B in net income in fiscal year 2025. This represents a decrease of 16.7% from the prior year.

EPS (Diluted)
$1.54
YoY-14.0%

Csx Corp earned $1.54 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 14.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$1.7B
YoY-37.0%
5Y CAGR-8.3%
10Y CAGR+7.8%

Csx Corp generated $1.7B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 37.0% from the prior year.

Cash & Debt
$670.0M
YoY-28.2%
5Y CAGR-26.5%
10Y CAGR+0.6%

Csx Corp held $670.0M in cash against $18.2B in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.52
YoY+8.3%

Csx Corp paid $0.52 per share in dividends in fiscal year 2025. This represents an increase of 8.3% from the prior year.

Shares Outstanding
1.86B
YoY-1.9%

Csx Corp had 1.86B shares outstanding in fiscal year 2025. This represents a decrease of 1.9% from the prior year.

Margins & Returns

Operating Margin
32.1%
YoY-4.0pp
5Y CAGR-9.1pp
10Y CAGR+1.7pp

Csx Corp's operating margin was 32.1% in fiscal year 2025, reflecting core business profitability. This is down 4.0 percentage points from the prior year.

Net Margin
20.5%
YoY-3.4pp
5Y CAGR-5.6pp
10Y CAGR+3.8pp

Csx Corp's net profit margin was 20.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.4 percentage points from the prior year.

Return on Equity
21.9%
YoY-5.8pp
5Y CAGR+0.9pp
10Y CAGR+5.1pp

Csx Corp's ROE was 21.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.8 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks
$1.4B
YoY-37.6%
5Y CAGR+10.0%
10Y CAGR+5.7%

Csx Corp spent $1.4B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 37.6% from the prior year.

Capital Expenditures
$2.9B
YoY+14.7%
5Y CAGR+12.3%
10Y CAGR+1.3%

Csx Corp invested $2.9B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 14.7% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

CSX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CSX annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$14.5B$14.1B-3.1%$14.5B-0.8%$14.7B-1.3%$14.9B+18.6%$12.5B+18.3%$10.6B-11.3%$11.9B-2.6%$12.3B+7.4%$11.4B+3.1%$11.1B-6.3%$11.8B-6.8%$12.7B+5.3%$12.0B+2.2%$11.8B-0.3%$11.8B
SG&A Expenses$3.3B$3.3B+3.1%$3.2B+3.7%$3.1B+5.8%$2.9B+13.1%$2.5B+12.1%$2.3B-13.0%$2.6B-4.5%$2.7B-7.1%$2.9B-6.0%$3.1B-4.7%$3.3B-2.6%$3.4B+7.6%$3.1B+3.9%$3.0B-1.7%$3.1B
Operating Income$5.0B$4.5B-13.8%$5.2B-4.6%$5.5B-7.6%$6.0B+6.4%$5.6B+28.2%$4.4B-12.1%$5.0B+2.0%$4.9B+30.9%$3.7B+9.0%$3.4B-4.8%$3.6B-0.8%$3.6B+4.0%$3.5B+0.3%$3.5B-0.2%$3.5B
Interest Expense$847.0M$844.0M+1.4%$832.0M+2.8%$809.0M+9.0%$742.0M+202.8%-$722.0M+4.2%-$754.0M-2.3%-$737.0M-15.3%-$639.0M-217.0%$546.0M-5.7%$579.0M+6.4%$544.0M-0.2%$545.0M-3.0%$562.0M-0.7%$566.0M+2.5%$552.0M
Income Tax$978.0M$880.0M-18.9%$1.1B-6.5%$1.2B-5.7%$1.2B+5.2%$1.2B+35.7%$862.0M-12.5%$985.0M-1.0%$995.0M+142.7%-$2.3B-326.8%$1.0B-12.2%$1.2B+4.7%$1.1B+5.6%$1.1B-4.5%$1.1B+2.0%$1.1B
Net Income$3.2B$2.9B-16.7%$3.5B-5.4%$3.7B-10.8%$4.1B+8.8%$3.8B+36.7%$2.8B-17.0%$3.3B+0.7%$3.3B-39.5%$5.5B+219.2%$1.7B-12.9%$2.0B+2.1%$1.9B+3.4%$1.9B+0.1%$1.9B+0.5%$1.9B
EPS (Diluted)$1.54-14.0%$1.79-1.6%$1.82-5.2%$1.92+14.3%$1.68$1.20-13.7%$1.39$3.84-35.9%$5.99+230.9%$1.81-9.5%$2.00+4.2%$1.92+4.9%$1.83+2.2%$1.79+5.3%$1.70

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CSX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CSX annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$43.7B+2.1%$42.8B+1.3%$42.2B+1.2%$41.7B+2.8%$40.5B+1.9%$39.8B+4.0%$38.3B+4.2%$36.7B+2.8%$35.7B+0.9%$35.4B+1.9%$34.7B+5.1%$33.1B+4.0%$31.8B+3.4%$30.7B+4.2%$29.5B
Current Assets$2.5B-9.6%$2.8B-16.0%$3.4B-11.8%$3.8B-1.7%$3.9B-12.8%$4.4B+35.5%$3.3B+27.8%$2.6B+33.9%$1.9B-23.0%$2.5B-12.4%$2.8B+10.4%$2.6B-1.2%$2.6B-11.9%$3.0B0.0%$3.0B
Cash & Equivalents$670.0M-28.2%$933.0M-31.0%$1.4B-30.9%$2.0B-12.6%$2.2B-28.4%$3.1B+226.6%$958.0M+11.7%$858.0M+114.0%$401.0M-33.5%$603.0M-4.0%$628.0M-6.1%$669.0M+13.0%$592.0M-24.5%$784.0M+0.1%$783.0M
Accounts Receivable$1.3B-2.1%$1.3B-4.8%$1.4B+6.1%$1.3B+14.4%$1.1B+25.9%$912.0M-7.5%$986.0M-2.4%$1.0B+4.1%$970.0M+3.4%$938.0M-4.5%$982.0M-13.0%$1.1B+7.3%$1.1B-5.6%$1.1B-2.9%$1.1B
Goodwill$80.0M-66.5%$239.0M-26.5%$325.0M+1.9%$319.0M+15.6%$276.0M+338.1%$63.0M0.0%$63.0MN/A$63.0M0.0%$63.0M0.0%$63.0M0.0%$63.0M-1.6%$64.0M0.0%$64.0M0.0%$64.0M
Total Liabilities$30.5B+0.9%$30.3B+0.1%$30.2B+3.5%$29.2B+8.1%$27.0B+1.3%$26.7B+1.1%$26.4B+9.3%$24.1B+14.9%$21.0B-11.4%$23.7B+2.8%$23.1B+5.5%$21.9B+2.8%$21.3B-1.4%$21.6B+3.3%$20.9B
Current Liabilities$3.1B-4.4%$3.3B+1.6%$3.2B+31.8%$2.4B+9.5%$2.2B+10.6%$2.0B-6.1%$2.2B+12.3%$1.9B+1.1%$1.9B-7.2%$2.0B+4.5%$2.0B-7.4%$2.1B-13.1%$2.4B-8.4%$2.6B+2.7%$2.6B
Long-Term Debt$18.2B+1.5%$17.9B-0.4%$18.0B+0.4%$17.9B+10.6%$16.2B-0.7%$16.3B+1.9%$16.0B+8.5%$14.7B+25.0%$11.8B+7.6%$11.0B+4.3%$10.5B+10.5%$9.5B+5.5%$9.0B-0.3%$9.1B+3.6%$8.7B
Total Equity$13.2B+5.2%$12.5B+4.4%$12.0B-3.9%$12.5B-7.3%$13.5B+2.6%$13.1B+10.5%$11.9B-5.7%$12.6B-14.5%$14.7B+25.9%$11.7B+0.2%$11.7B+4.4%$11.2B+6.4%$10.5B+15.0%$9.1B+6.3%$8.6B
Retained Earnings$10.6B+5.7%$10.0B+3.9%$9.6B-6.1%$10.2B-12.0%$11.6B+3.3%$11.3B-1.3%$11.4B-6.2%$12.2B-13.7%$14.1B+25.2%$11.3B+0.1%$11.2B+4.7%$10.7B+8.0%$9.9B+10.3%$9.0B+7.2%$8.4B

Not reported in any period shown, so not listed: Inventory.

CSX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CSX annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$5.3B$4.6B-12.1%$5.2B-4.8%$5.5B-0.2%$5.5B+8.4%$5.1B+19.6%$4.3B-12.1%$4.8B+4.5%$4.6B+33.7%$3.5B+14.2%$3.0B-9.8%$3.4B+0.8%$3.3B+2.3%$3.3B+10.9%$2.9B-15.6%$3.5B
Capital Expenditures$2.5B$2.9B+14.7%$2.5B+12.1%$2.3B+6.8%$2.1B+18.0%$1.8B+10.1%$1.6B-1.9%$1.7B-5.0%$1.7B-14.5%$2.0B-14.9%$2.4B-6.4%$2.6B+4.6%$2.4B+5.9%$2.3B-1.2%$2.3B+1.9%$2.3B
Free Cash Flow$2.8B$1.7B-37.0%$2.7B-16.5%$3.3B-4.6%$3.4B+3.2%$3.3B+25.4%$2.6B-17.4%$3.2B+10.3%$2.9B+102.2%$1.4B+122.7%$643.0M-20.4%$808.0M-9.6%$894.0M-6.3%$954.0M+57.7%$605.0M-49.3%$1.2B
Investing Cash Flow-$2.7B-$2.9B-9.4%-$2.6B-17.0%-$2.2B-7.9%-$2.1B-9.9%-$1.9B-189.2%-$649.0M+69.1%-$2.1B-24.8%-$1.7B-12.6%-$1.5B+16.9%-$1.8B+37.8%-$2.9B-32.5%-$2.2B+2.0%-$2.2B+2.2%-$2.3B+12.0%-$2.6B
Financing Cash Flow-$2.0B-$2.0B+33.9%-$3.1B+20.8%-$3.9B-2.6%-$3.8B+8.3%-$4.1B-185.0%-$1.4B+45.5%-$2.6B-5.9%-$2.5B-14.7%-$2.2B-71.8%-$1.3B-144.3%-$519.0M+52.1%-$1.1B+12.1%-$1.2B-84.4%-$668.0M+52.7%-$1.4B
Dividends Paid$1.0B$972.0M+4.5%$930.0M+5.4%$882.0M+3.5%$852.0M+1.5%$839.0M+5.3%$797.0M+4.5%$763.0M+1.6%$751.0M+6.1%$708.0M+4.1%$680.0M-0.9%$686.0M+9.1%$629.0M+4.8%$600.0M+7.5%$558.0M+16.3%$480.0M
Share Buybacks$742.0M$1.4B-37.6%$2.2B-35.8%$3.5B-26.4%$4.7B+63.9%$2.9B+232.9%$867.0M-74.3%$3.4B-27.8%$4.7B+137.1%$2.0B+86.6%$1.1B+31.3%$804.0M+55.5%$517.0M+46.5%$353.0M-51.9%$734.0M-53.1%$1.6B

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CSX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CSX annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Margin32.1%-4.0pp36.1%-1.4pp37.5%-2.6pp40.1%-4.6pp44.7%+3.4pp41.2%-0.4pp41.6%+1.8pp39.8%+7.1pp32.6%+1.8pp30.8%+0.5pp30.3%+1.8pp28.5%-0.4pp28.9%-0.6pp29.4%0.0pp29.4%
Net Margin20.5%-3.4pp23.9%-1.2pp25.0%-2.7pp27.7%-2.5pp30.2%+4.1pp26.1%-1.8pp27.9%+0.9pp27.0%-21.0pp48.0%+32.5pp15.5%-1.2pp16.7%+1.4pp15.2%-0.3pp15.5%-0.3pp15.8%+0.1pp15.7%
Return on Equity21.9%-5.8pp27.7%-2.9pp30.6%-2.4pp33.0%+4.9pp28.1%+7.0pp21.1%-7.0pp28.1%+1.8pp26.3%-10.9pp37.2%+22.5pp14.7%-2.2pp16.9%-0.4pp17.2%-0.5pp17.8%-2.6pp20.4%-1.2pp21.6%
Return on Assets6.6%-1.5pp8.1%-0.6pp8.7%-1.2pp9.9%+0.5pp9.3%+2.4pp7.0%-1.8pp8.7%-0.3pp9.0%-6.3pp15.3%+10.5pp4.8%-0.8pp5.7%-0.2pp5.8%0.0pp5.9%-0.2pp6.1%-0.2pp6.3%
Current Ratio0.810.0x0.86-0.2x1.04-0.5x1.56-0.2x1.73-0.5x2.20+0.7x1.52+0.2x1.34+0.3x1.01-0.2x1.22-0.2x1.45+0.2x1.22+0.1x1.070.0x1.120.0x1.15
Debt-to-Equity1.38-0.1x1.43-0.1x1.50+0.1x1.44+0.2x1.200.0x1.24-0.1x1.35+0.2x1.17+0.4x0.80-0.1x0.940.0x0.900.0x0.850.0x0.86-0.1x0.990.0x1.02
FCF Margin12.1%-6.6pp18.7%-3.5pp22.2%-0.8pp23.0%-3.4pp26.4%+1.5pp24.9%-1.8pp26.8%+3.1pp23.6%+11.1pp12.6%+6.7pp5.8%-1.0pp6.8%-0.2pp7.1%-0.9pp7.9%+2.8pp5.1%-5.0pp10.1%

Not reported in any period shown, so not listed: Gross Margin.

Note: The current ratio is below 1.0 (0.81), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Csx Corp's annual revenue?

Csx Corp (CSX) reported $14.1B in total revenue for fiscal year 2025. This represents a -3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Csx Corp's revenue growing?

Csx Corp (CSX) revenue declined by 3.1% year-over-year, from $14.5B to $14.1B in fiscal year 2025.

Is Csx Corp profitable?

Yes, Csx Corp (CSX) reported a net income of $2.9B in fiscal year 2025, with a net profit margin of 20.5%.

Csx Corp (CSX) reported diluted earnings per share of $1.54 for fiscal year 2025. This represents a -14.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Csx Corp (CSX) had EBITDA of $6.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Csx Corp (CSX) had $670.0M in cash and equivalents against $18.2B in long-term debt.

Csx Corp (CSX) had an operating margin of 32.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Csx Corp (CSX) had a net profit margin of 20.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Csx Corp (CSX) paid $0.52 per share in dividends during fiscal year 2025.

Csx Corp (CSX) has a return on equity of 21.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Csx Corp (CSX) generated $1.7B in free cash flow during fiscal year 2025. This represents a -37.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Csx Corp (CSX) generated $4.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Csx Corp (CSX) had $43.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Csx Corp (CSX) invested $2.9B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Csx Corp (CSX) spent $1.4B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Csx Corp (CSX) had 1.86B shares outstanding as of fiscal year 2025.

Csx Corp (CSX) had a current ratio of 0.81 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Csx Corp (CSX) had a debt-to-equity ratio of 1.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Csx Corp (CSX) had a return on assets of 6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Csx Corp (CSX) has an Altman Z-Score of 2.83, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Csx Corp (CSX) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Csx Corp (CSX) has an earnings quality ratio of 1.60x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Csx Corp (CSX) has an interest coverage ratio of 5.36x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Csx Corp (CSX) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top